http://purl.uniprot.org/citations/25479371 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/25479371 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundPrevious studies have shown that the expression level of γ-synuclein (SNCG) is associated with progression of many different malignant tumors. In this study, we discuss and assess the prognostic ability of SNCG in bladder cancer.Material and methodsMedical records (2005-2013) were retrospectively reviewed for the population of interest. SNCG expression was identified immunohistochemically from bladder cancer tissues of 113 bladder cancer patients. The survival rate was calculated by the Kaplan-Meier method. Cox proportional hazard regression model was used for analysis of predictors of bladder cancer.ResultsSNCG was overexpressed in bladder cancer tissues compared with the normal bladder tissues (p<0.0001). SNCG expression in bladder cancer tissue was strongly related to tumor stage. However, SNCG level was not a prognostic factor of survival.ConclusionsOur results demonstrate that SNCG is highly expressed in bladder cancer tissue and its expression is stage-specific, but it is not helpful for predicting outcome in bladder cancer patients."xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.org/dc/terms/identifier | "doi:10.12659/msm.892927"xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/author | "Zhao J."xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/author | "Xing N."xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/date | "2014"xsd:gYear |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/name | "Med Sci Monit"xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/pages | "2550-2555"xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/title | "Identification of gamma-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry."xsd:string |
http://purl.uniprot.org/citations/25479371 | http://purl.uniprot.org/core/volume | "20"xsd:string |
http://purl.uniprot.org/citations/25479371 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/25479371 |
http://purl.uniprot.org/citations/25479371 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/25479371 |
http://purl.uniprot.org/uniprot/#_A9XXE1-mappedCitation-25479371 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/#_F8W754-mappedCitation-25479371 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/#_O76070-mappedCitation-25479371 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/#_Q6FHG5-mappedCitation-25479371 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/A9XXE1 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/F8W754 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/O76070 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25479371 |
http://purl.uniprot.org/uniprot/Q6FHG5 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/25479371 |